HYPOGONADISM IN METABOLIC SYNDROME PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 1
Abstract
Introduction. Previous studies have shown a high prevalence of low levels of the endogenous sexual hormones in patients with metabolic syndrome (MetS). The aim of this study was to analyze the prevalence of hypogonadism in MetS patients. Materials and Methods. We analyzed the relationship between testosterone levels and components of metabolic syndrome in 381 patients. These patients were divided into two groups: group A – patients with metabolic syndrome (MetS) and hypogonadism (MetS+T) and group B – patients with metabolic syndrome without hypogonadism (MetS-T). Overweight was defined as BMI 26-29.9kg/m2. Obesity was defined as BMI≥30 kg/m2. Male hypogonadism or androgen deficiency has been defined as a maximum level of total testosterone up to 3 ng/ml. Results. There were no significant age differences between groups (59.8±8.38 versus 58.31±7.47 years p=0.06). Prevalence of hypogonadism in metabolic syndrome patients was 33.5% (n=128). There were no significant differences between groups in terms of body weight, waist circumference, hip circumference, BMI and blood pressure between groups (all p>0.05). Patients with hypogonadism had significantly higher levels of triglycerides, FPI, HOMA-IR (all p<0.05) and smaller HDL-cholesterol and SHBG (all p<0.05). There was a significant decline in testosterone concentration with increase in age and BMI. 88.3% of the diabetic patients (n=113) had hypogonadism (p=0.0001). Hypogonadism was present in 25% patients (n=32) with 3 components of MetS, 43.8% (n=56) patients with 4 componets of MetS and in 31.2% (n=40) patients with 5 components of MetS (p=0.0001). Conclusions. Hypogonadism is a common occurrence in subjects with MetS. Males with MetS with or without diabetes have lower serum testosterone. Patients with MetS should be investigated for clinical and biochemical signs of hypogonadism and patients with hypogonadism should be investigated for signs of metabolic syndrome.
Authors and Affiliations
Florin Rusu, Emilia Rusu, Gabriela Radulian, Georgiana Enache, Mariana Jinga, Viorel Jinga, Carmen Radu, Dan Mischianu, Dan Mircea Cheţa
Keywords
Related Articles
- EP ID EP155377
- DOI -
- Views 95
- Downloads 0
THE REDUCTION OF WEIGHT TROUGH RESTRICTIVE DIET AT OVERWEIGHT FEMALE WITH POLYCYSTIC OVARY SYNDROME COMPARED TO THE OVERWEIGHT FEMALE WITHOUT POLYCYSTIC OVARY SYNDROME
Polycystic ovary syndrome is the most frequent endocrinopathy in reproductive-aged women. The classic symptoms include hirsutism, acnea, overweight, oligo or amenorrhea, infertility. We have compared the effect of the re...
DIABETES IN PREGNANCY: PREPREGNANCY CARE FOR TYPE 1 AND TYPE 2 DIABETES
Preconception counseling is the education of, and the discussion with, women of reproductive age about pregnancy and contraception. It is essential component of every consultation in primary and/or specialist care. Preco...
HEPATIC STEATOSIS IN PATIENTS WITH HEPATITIS C
Aims: The aims of this study was to indentify independent predictive factors of liver steatosis in patients with hepatitis C and to examine the correlations between ultrasound-diagnosed HS and anthropometric, clinical, b...
DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC
This study evaluated the efficacy and safety of Ezetimibe co-administered with Simvastatine therapy in 104 hypercholesterolemic patients with coronary heart disease (CHD) or diabetes who had not achieved their low-densit...
VITAMIN D DEFICIENCY EFFECTS UPON DIABETES MELLITUS AND ITS CARDIOVASCULAR AND RENAL CHRONIC COMPLICATIONS
Vitamin D was proved to have multiple non-skeletal actions, its receptor being expressed by almost every tissue, consequently proper levels being necessary for their optimal functioning. Although biologically inactive, 2...